Johnson & Johnson said the U.S. Justice Department is investigating the company over drug pricing and its arthritis medication. Fred Katayama reports.
Johnson & Johnson's regulatory documents revealed the company is facing several government investigations. Some of them are looking into the ways it prices its drugs. Specifically, the government is trying to find out whether it has been paying too much for the hepatitis C drugs covered by Medicaid. Reuters correspondent Caroline Humer says the J&J investigation could be a piece of a bigger puzzle. (SOUNDBITE) CAROLINE HUMER, REUTERS CORRESPONDENT, (ENGLISH) SAYING: "The fact that they've gone to one of the biggest drug makers indicates that this is a very wide look at the industry. And the impact on J&J, which is such a big company, would be minimal from an investor's point of view." Johnson & Johnson is also under a civil investigation by the Justice Department. That probe is looking into a doctor's office that is selling J&J's arthritis drugs.